Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-7364
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients ; volume:14 ; number:1 ; day:11 ; month:9 ; year:2020 ; pages:1-6 ; date:12.2020
Human genomics ; 14, Heft 1 (11.9.2020), 1-6, 12.2020
- Urheber
-
Novelli, Antonio
Biancolella, Michela
Borgiani, Paola
Cocciadiferro, Dario
Colona, Vito Luigi
D’Apice, Maria Rosaria
Rogliani, Paola
Zaffina, Salvatore
Leonardis, Francesca
Campana, Andrea
Raponi, Massimiliano
Andreoni, Massimo
Grelli, Sandro
Novelli, Giuseppe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40246-020-00279-z
- URN
-
urn:nbn:de:101:1-2020103118320451334010
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Novelli, Antonio
- Biancolella, Michela
- Borgiani, Paola
- Cocciadiferro, Dario
- Colona, Vito Luigi
- D’Apice, Maria Rosaria
- Rogliani, Paola
- Zaffina, Salvatore
- Leonardis, Francesca
- Campana, Andrea
- Raponi, Massimiliano
- Andreoni, Massimo
- Grelli, Sandro
- Novelli, Giuseppe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants
ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study
An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants
ACE2: the molecular doorway to SARS-CoV-2
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2
Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants
ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study
An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants
ACE2: the molecular doorway to SARS-CoV-2
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2
Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants
ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study
An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants
ACE2: the molecular doorway to SARS-CoV-2
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry